Merck fell 2.07% at Rs 582.05 at 14:11 IST on BSE after net profit declined 17.2% to Rs 16.68 crore on 11.9% rise in net sales to Rs 200.29 crore in Q2 June 2013 over Q2 June 2012.
The result was announced after market hours on Monday, 29 July 2013.
Meanwhile, the BSE Sensex was down 140.97 points, or 0.72%, to 19,452.31
On BSE, 704 shares were traded in the counter as against an average daily volume of 2,349 shares in the past one quarter.
The stock hit a high of Rs 604 and a low of Rs 582 so far during the day. The stock had hit a 52-week high of Rs 699 on 10 September 2012. The stock had hit a 52-week low of Rs 530 on 9 April 2013.
The stock had underperformed the market over the past one month till 29 July 2013, falling 8.87% compared with the Sensex's 1.02% rise. The scrip had also underperformed the market in past one quarter, declining 4.59% as against Sensex's 1.06% rise
The small-cap company has an equity capital of Rs 16.60 crore. Face value per share is Rs 10.
Merck has business interests in pharmaceuticals and chemicals.
Powered by Capital Market - Live News
